22 December 2005
Prevalence and risk factors for HEV infection in pregnant women.
Serkan Oncu, Selcen Oncu, Pinar Okyay, Sema Ertug, Serhan SakaryaMed Sci Monit 2006; 12(1): CR36-39 :: ID: 443191
Abstract
Background: Hepatitis E is an infectious viral disease with clinical andmorphological features of acute hepatitis, clinically similar to other forms of acute viral hepatitisexcept in pregnant women, in whom the illness is particularly severe and has a high mortality rate. Thepresent study was conducted in western Turkey to investigate the prevalence and risk factors for HEVinfection in pregnant women. Material/Methods: The data for the study were acquired from health centersin urban and rural areas of Aydin province, Turkey. The study design was cross-sectional. Multistagesampling was used to select the study group. Samples were tested for anti-HEV IgG by commercial ELISAtest. Results: A total of 386 pregnant women were included in the study. Antibodies against HEV weredetected in 27 of the 386 pregnant women (7.0%). The prevalence of HEV seropositivity was significantlylower (2.5%) in women with a higher education level when compared to women with a lower education level(9.7%) (p=0.023). No significant differences were identified between seropositive and seronegative womenin terms of age, source of water supply and place of residence. Conclusions: According to our results,education seems to be the only factor affecting the prevalence of HEV infection in pregnant women. Theprevalence rate we found was similar to the results obtained in previous community-based studies conductedin western Turkey.
Keywords: Antibodies, Viral - blood, Hepatitis E - physiopathology, Hepatitis E virus, Pregnancy, Pregnancy Complications, Infectious, Questionnaires, Risk Factors, Turkey - epidemiology
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
15 Mar 2024 : Clinical Research
Impact of One-Lung Ventilation on Oxygenation and Ventilation Time in Thoracoscopic Heart Surgery: A Compar...Med Sci Monit In Press; DOI: 10.12659/MSM.943089
14 Mar 2024 : Clinical Research
Differential DHA and EPA Levels in Women with Preterm and Term Births: A Tertiary Hospital Study in IndonesiaMed Sci Monit In Press; DOI: 10.12659/MSM.943895
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952